Average Co-Inventor Count = 7.43
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Janssen Pharmaceutica Nv (33 from 2,078 patents)
2. The Wistar Institute (7 from 243 patents)
3. Biohaven Pharmaceutical Holding Company Limited (5 from 8 patents)
4. Rutgers, the State University of New Jersey (4 from 1,455 patents)
5. Oligomerix, Inc. (3 from 10 patents)
6. Ortho-mcneil Pharmaceutical Corp. (2 from 363 patents)
7. Kannalife Sciences, Inc. (2 from 2 patents)
8. Janseen Pharmacautica Nv (1 from 1 patent)
53 patents:
1. 12331043 - Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use
2. 12258314 - EBNA1 inhibitors and their method of use
3. 12172974 - Prodrugs of riluzole and their method of use
4. 11912659 - EBNA1 inhibitors and methods using same
5. 11472776 - Quinazolinones that inhibit the formation of tau oligomers and their method of use
6. 11440893 - Prodrugs of riluzole and their method of use
7. 11306075 - Benzofuran, benzothiophene, and indole analogs that inhibit the formation of tau oligomers and their method of use
8. 11242317 - EBNA1 inhibitors and their method of use
9. 10981867 - EBNA1 inhibitors and methods using same
10. 10844026 - Prodrugs of riluzole and their method of use
11. 10562870 - Prodrugs of riluzole and their method of use
12. 10442763 - EBNA1 inhibitors and methods using same
13. 10421718 - EBNA1 inhibitors and their method of use
14. 10004722 - Method for treating hepatic encephalopathy or a disease associated with free radical mediate stress and oxidative stress with novel functionalized 1,3-benzene diols
15. 9856214 - EBNA1 inhibitors and their method of use